
Preterm Birth Prevention And Management Market Report 2026
Global Outlook – By Product Type (Pharmaceuticals, Medical Devices, Therapies), By Cause-Specific (Multiple Pregnancy, Infection And Chronic Conditions, Structural Abnormalities, Maternal Lifestyle Factors), By Diagnosis Method (Ultrasound Imaging, Biochemical Tests, Physical Examination), By End-User (Hospitals, Clinics, Homecare Settings, Diagnostic Laboratories) - Market Size, Trends, And Global Forecast 2026-2035
Preterm Birth Prevention And Management Market Overview
• Preterm Birth Prevention And Management market size has reached to $2 billion in 2025 • Expected to grow to $2.86 billion in 2030 at a compound annual growth rate (CAGR) of 7.3% • Growth Driver: Growing Awareness Of Maternal And Fetal Health Fueling The Growth Of The Market Due To Increasing Healthcare Access Education And Government Initiatives • Market Trend: Innovative Campaigns Promote Early Intervention For Maternal Health • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Preterm Birth Prevention And Management Market?
Preterm birth prevention and management refers to a range of strategies aimed at reducing the risk of babies being born before 37 weeks of gestation and addressing complications associated with early delivery. These strategies involve interventions during pregnancy and after birth to ensure the health and safety of both the mother and baby. The main types of products in preterm birth prevention and management are pharmaceuticals, medical devices, and therapies. Pharmaceuticals refer to medicinal drugs used to prevent or manage preterm labor, including therapies such as progesterone supplements and tocolytics. These are tailored to address specific causes such as multiple pregnancies, infection and chronic conditions, structural abnormalities, and maternal lifestyle factors for various diagnosis methods such as ultrasound imaging, biochemical tests, and physical examination. It includes various end users such as hospitals, clinics, homecare settings, and diagnostic laboratories.
What Is The Preterm Birth Prevention And Management Market Size and Share 2026?
The preterm birth prevention and management market size has grown strongly in recent years. It will grow from $2 billion in 2025 to $2.16 billion in 2026 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to increased awareness of maternal health risks, expansion of prenatal care access, improved diagnostic capabilities, growing use of pharmaceutical interventions, increased monitoring of high-risk pregnancies.What Is The Preterm Birth Prevention And Management Market Growth Forecast?
The preterm birth prevention and management market size is expected to see strong growth in the next few years. It will grow to $2.86 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to increasing prevalence of high-risk pregnancies, rising investments in maternal healthcare infrastructure, growing adoption of digital prenatal monitoring, expansion of telemedicine in obstetric care, increasing focus on neonatal outcome optimization. Major trends in the forecast period include increasing adoption of early risk screening programs, rising use of advanced prenatal monitoring technologies, growing focus on personalized pregnancy care, expansion of preventive therapeutic interventions, enhanced integration of multidisciplinary care models.Global Preterm Birth Prevention And Management Market Segmentation
1) By Product Type: Pharmaceuticals, Medical Devices, Therapies 2) By Cause-Specific: Multiple Pregnancy, Infection And Chronic Conditions, Structural Abnormalities, Maternal Lifestyle Factors 3) By Diagnosis Method: Ultrasound Imaging, Biochemical Tests, Physical Examination 4) By End-User: Hospitals, Clinics, Homecare Settings, Diagnostic Laboratories Subsegments: 1) By Pharmaceuticals: Tocolytics, Corticosteroids, Progesterone Therapy, Magnesium Sulfate 2) By Medical Devices: Cervical Cerclage Devices, Fetal Monitoring Devices, Uterine Contraction Monitors 3) By Therapies: Bed Rest Therapy, Nutritional Therapy, Cervical Pessary TherapyWhat Is The Driver Of The Preterm Birth Prevention And Management Market?
The growing awareness of maternal and fetal health is expected to propel the growth of the preterm birth prevention and management market going forward. Maternal and fetal health refers to the well-being of pregnant women and their unborn babies, ensuring safe pregnancies and healthy outcomes. Awareness of maternal and fetal health is growing as educational campaigns and awareness programs are actively promoting the importance of prenatal care, proper nutrition, vaccination, and regular screenings to ensure healthier pregnancy outcomes. Preterm birth prevention and management are essential for maternal and fetal health, as they help reduce complications such as respiratory distress and developmental delays in newborns while also lowering maternal health risks associated with premature delivery. For instance, in July 2024, according to the Welsh Government (Llywodraeth Cymru), a UK-based governing body, in 2023, the percentage of pregnant women with a BMI of 30 or higher at their initial assessment increased to 32%, reflecting a 0.8 percentage point rise from the previous year. Therefore, the growing awareness of maternal and fetal health is driving the growth of the preterm birth prevention and management industry.Key Players In The Global Preterm Birth Prevention And Management Market
Major companies operating in the preterm birth prevention and management market are Philips Healthcare, GE Healthcare Technologies Inc, Hologic Inc, QIAGEN NV, Ferring Pharmaceuticals, AMAG Pharmaceuticals, Natus Medical Incorporated, Sera Prognostics, Progenity Inc, CooperSurgical Inc, Medtronic plc, Abbott Laboratories, Siemens Healthineers AG, Roche Diagnostics International AG, Thermo Fisher Scientific Inc, Danaher Corporation, BD Becton Dickinson And Company, Olympus Corporation, Fujifilm Holdings Corporation, Cook Medical LLC, Karl Storz SE And Co KG, Baxter International IncGlobal Preterm Birth Prevention And Management Market Trends and Insights
Major companies operating in the preterm birth prevention and management market are developing initiatives, such as the campaign to combat preeclampsia and preterm birth, to raise awareness and improve care for preterm infants. A campaign to combat preeclampsia and preterm birth focuses on raising awareness, promoting research, improving healthcare interventions, and advocating for policies that enhance maternal and neonatal health outcomes. For instance, in May 2024, March of Dimes Inc., a US-based nonprofit organization, launched the Low Dose, Big Benefits campaign, a long-term initiative designed to lower the risks of preeclampsia and preterm birth through the use of low-dose aspirin. Preeclampsia, a serious pregnancy complication affecting 1 in 25 pregnancies, can be mitigated with low-dose aspirin, reducing the risk by up to 15% for preeclampsia and 20% for preterm birth in high-risk pregnancies. The campaign aims to address a significant knowledge gap, as many families, especially Black families, are unaware of preeclampsia.What Are Latest Mergers And Acquisitions In The Preterm Birth Prevention And Management Market?
In February 2024, Novocuff Inc., a US-based medical device company, partnered with Fogarty Innovation (FI) to further its mission of preventing preterm births and improving pregnancy outcomes. This collaboration aims to advance its cervical control device aimed at preventing preterm births, receiving a six-month mentorship through Fogarty's Company Accelerator Program to refine its technology and prepare for a pivotal U.S. multi-center clinical trial in early 2025, with the goal of global commercialization. Fogarty Innovation (FI) is a US-based nonprofit educational incubator dedicated to advancing medical innovation that improves human health.Regional Outlook
North America was the largest region in the preterm birth prevention and management market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Preterm Birth Prevention And Management Market?
The preterm birth prevention and management market includes revenues earned by entities by providing services such as prenatal screening and risk assessment, maternal health monitoring, pharmaceutical and therapeutic interventions, neonatal intensive care (NICU) services, and postnatal rehabilitation and support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Preterm Birth Prevention And Management Market Report 2026?
The preterm birth prevention and management market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the preterm birth prevention and management industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Preterm Birth Prevention And Management Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $2.16 billion |
| Revenue Forecast In 2035 | $2.86 billion |
| Growth Rate | CAGR of 7.7% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product Type, Cause-Specific, Diagnosis Method, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Philips Healthcare, GE Healthcare Technologies Inc, Hologic Inc, QIAGEN NV, Ferring Pharmaceuticals, AMAG Pharmaceuticals, Natus Medical Incorporated, Sera Prognostics, Progenity Inc, CooperSurgical Inc, Medtronic plc, Abbott Laboratories, Siemens Healthineers AG, Roche Diagnostics International AG, Thermo Fisher Scientific Inc, Danaher Corporation, BD Becton Dickinson And Company, Olympus Corporation, Fujifilm Holdings Corporation, Cook Medical LLC, Karl Storz SE And Co KG, Baxter International Inc |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
